beta 2 Adrenergic Receptor Antikörper (AA 201-300)
(2 Referenzen)Kurzübersicht für beta 2 Adrenergic Receptor Antikörper (AA 201-300) (ABIN730153)
Target
Alle beta 2 Adrenergic Receptor (ADRB2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Verwendungszweck
- ADRB2 Polyclonal Antibody
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human of human ADRB2
-
Isotyp
- IgG
-
-
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (AA 302-413) antibody
ADRB2 Reaktivität: Human, Ratte WB, ELISA, FACS Wirt: Maus Monoclonal 5G3B5 unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (AA 1-413) antibodyADRB2 Reaktivität: Human WB, FACS Wirt: Maus Polyclonal unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (AA 1-413) antibodyADRB2 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (C-Term) antibodyVerified ADRB2 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (C-Term) antibodyADRB2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (AA 345-373) antibodyADRB2 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB16260 unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (AA 15-30), (Extracellular), (N-Term) antibodyADRB2 Reaktivität: Maus WB, IHC, FACS, LCI Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) antibodyADRB2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Monoclonal 4C11 unconjugated Recombinant Antibody
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) antibodyADRB2 Reaktivität: Human WB, FACS Wirt: Kaninchen Monoclonal 23GB3165 unconjugated Recombinant Antibody
anti-Adrenergic, beta-2-, Receptor, Surface (ADRB2) (AA 334-413) antibodyADRB2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB(1:500-2000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model." in: Journal of experimental & clinical cancer research : CR, Vol. 33, pp. 21, (2014) (PubMed).
: "Role of ?2-adrenoceptor-?-arrestin2-nuclear factor-?B signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis." in: Chinese journal of integrative medicine, Vol. 18, Issue 7, pp. 514-21, (2012) (PubMed).
-
-
- beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
-
Andere Bezeichnung
- ADRB2
-
Hintergrund
-
Synonyms: BAR, B2AR, ADRBR, ADRB2R, BETA2AR, Beta-2 adrenergic receptor, Beta-2 adrenoreceptor, Beta-2 adrenoceptor, ADRB2
Background: Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 3-fold greater affinity than it does norepinephrine.
-
Gen-ID
- 154
-
UniProt
- P07550
-
Pathways
- cAMP Metabolic Process, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
Target
-
